back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-28 22:07 Tx date 2025-03-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+5,000 vol $0.09 each |
1,145,002 | |
| Filed 2025-03-28 22:07 Tx date 2025-03-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150.00
+2,000 vol $0.075 each |
1,140,002 | |
| Filed 2025-03-25 22:54 Tx date 2025-03-25 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-500,000 vol |
623,000 | |
| Filed 2025-03-25 22:36 Tx date 2025-03-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+700,000 vol |
1,123,000 | |
| Filed 2025-01-19 20:50 Tx date 2025-01-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$425.00
+5,000 vol $0.085 each |
1,138,002 | |
| Filed 2024-11-16 09:57 Tx date 2024-11-15 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+15,000 vol $0.08 each |
1,133,002 | |
| Filed 2024-10-10 08:22 Tx date 2024-10-07 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$800.00
+10,000 vol $0.08 each |
1,118,002 | |
| Filed 2024-08-02 16:29 Tx date 2024-08-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$50,760
+423,000 vol $0.12 each |
423,000 | |
| Filed 2024-08-02 16:25 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-08-02 16:22 Tx date 2024-08-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,760
+423,000 vol $0.12 each |
423,000 | |
| Filed 2024-08-02 16:19 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-27 17:34 Tx date 2024-06-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,145
+19,500 vol $0.11 each |
1,108,002 | |
| Filed 2024-06-20 16:27 Tx date 2024-06-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+4,500 vol $0.12 each |
1,088,502 | |
| Filed 2024-06-06 12:04 Tx date 2024-06-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$350.00
+2,500 vol $0.14 each |
1,084,002 | |
| Filed 2024-06-06 12:04 Tx date 2024-06-04 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,680
+12,000 vol $0.14 each |
1,081,502 | |
| Filed 2024-05-17 14:32 Tx date 2024-05-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,914
+27,000 vol $0.145 each |
1,069,502 | |
| Filed 2024-05-17 14:31 Tx date 2024-05-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$420.00
+3,000 vol $0.14 each |
1,042,502 | |
| Filed 2024-04-27 09:08 Tx date 2024-04-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,940
+38,000 vol $0.13 each |
1,039,502 | |
| Filed 2024-02-07 20:33 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+600,000 vol |
1,601,502 | |
| Filed 2024-02-07 19:05 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-48,000
-600,000 vol $0.08 each |
1,001,502 | |
| Filed 2024-02-07 19:03 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$360,000,000,000
+600,000 vol $600,000 each |
||
| Filed 2024-02-07 19:03 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$360,000,000,000
+600,000 vol $600,000 each |
1,601,502 | |
| Filed 2024-02-07 19:02 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-600,000 vol |
0 | |
| Filed 2024-02-04 10:49 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+600,000 vol |
600,000 | |
| Filed 2024-01-04 15:48 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+240,000 vol |
1,001,502 | |
| Filed 2024-01-04 15:47 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-240,000 vol |
0 | |
| Filed 2023-12-29 17:31 Tx date 2023-12-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+60,000 vol $0.075 each |
761,502 | |
| Filed 2023-12-28 18:02 Tx date 2023-12-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+533,400 vol |
569,434 | |
| Filed 2023-12-28 18:01 Tx date 2023-12-28 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,650
+60,000 vol $0.0775 each |
701,502 | |
| Filed 2023-12-28 18:00 Tx date 2023-12-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$40,005
+533,400 vol $0.075 each |
641,502 | |
| Filed 2023-05-09 19:06 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+36,034 vol |
36,034 | |
| Filed 2023-05-09 19:06 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,008
+36,034 vol $0.25 each |
108,102 | |
| Filed 2023-05-09 19:05 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-36,034 vol |
0 | |
| Filed 2023-05-09 19:05 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-36,034 vol |
36,034 | |
| Filed 2023-04-17 21:56 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+72,068 vol |
72,068 | |
| Filed 2023-04-17 21:55 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-14 13:14 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+60,000 vol |
278,000 | |
| Filed 2023-03-14 13:13 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+96,000 vol |
218,000 | |
| Filed 2023-03-14 13:12 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+37,500 vol |
122,000 | |
| Filed 2023-03-14 13:11 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+15,000 vol |
84,500 | |
| Filed 2023-03-14 13:09 Tx date 2023-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
55 - Expiration of warrants
|
-2,500 vol |
69,500 | |
| Filed 2023-03-14 13:08 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+180,000 vol |
240,000 | |
| Filed 2023-03-14 13:03 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+54,051 vol |
72,068 | |
| Filed 2022-09-05 18:56 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+60,000 vol |
60,000 | |
| Filed 2022-09-05 18:55 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
72,000 | |
| Filed 2022-01-21 19:31 Tx date 2021-08-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-425,000 vol |
0 | |
| Filed 2022-01-17 12:41 Tx date 2022-01-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,000 vol |
52,000 | |
| Filed 2022-01-17 12:39 Tx date 2022-01-12 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,769
+640 vol $5.89 each |
18,017 | |
| Filed 2022-01-17 12:37 Tx date 2021-11-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+800 vol $5.00 each |
15,327 | |
| Filed 2021-11-30 22:14 Tx date 2021-11-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,000
+4,800 vol $5.00 each |
||
| Filed 2022-01-07 14:47 Tx date 2022-01-07 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$500.00
+100 vol $5.00 each |
21,377 | |
| Filed 2022-01-07 14:47 Tx date 2022-01-06 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$107.75
+25 vol $4.31 each |
21,277 | |
| Filed 2022-01-07 14:46 Tx date 2022-01-06 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+225 vol $4.40 each |
21,252 | |
| Filed 2021-12-31 13:11 Tx date 2021-12-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,170
+500 vol $4.34 each |
21,027 | |
| Filed 2021-12-16 14:42 Tx date 2021-12-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+400 vol $5.00 each |
20,527 | |
| Filed 2021-12-16 10:39 Tx date 2021-12-15 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,040
+200 vol $5.20 each |
20,127 | |
| Filed 2021-12-16 10:39 Tx date 2021-12-15 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,100
+200 vol $5.50 each |
19,927 | |
| Filed 2021-12-16 10:38 Tx date 2021-12-15 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,142
+200 vol $5.71 each |
19,727 | |
| Filed 2021-11-30 22:15 Tx date 2021-11-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,980,000 vol |
20,000 | |
| Filed 2021-11-30 22:14 Tx date 2021-11-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,098
+200 vol $5.49 each |
19,527 | |
| Filed 2021-11-30 22:14 Tx date 2021-11-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,000
+4,800 vol $5.00 each |
19,327 | |
| Filed 2021-11-30 22:13 Tx date 2021-11-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,438,250 vol |
14,527 | |
| Filed 2021-02-04 12:11 Tx date 2021-02-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+283,989 vol |
1,452,777 | |
| Filed 2021-02-04 12:10 Tx date 2021-02-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-412,500 vol |
425,000 | |
| Filed 2020-12-18 19:36 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+268,788 vol |
1,168,788 | |
| Filed 2020-12-18 19:36 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-412,500 vol |
837,500 | |
| Filed 2020-08-27 13:30 Tx date 2020-08-21 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+1,250,000 vol |
1,250,000 | |
| Filed 2020-08-27 13:27 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-12 15:12 Tx date 2020-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,250,000 vol |
2,000,000 | |
| Filed 2020-06-12 15:11 Tx date 2020-02-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
750,000 | |
| Filed 2020-06-12 15:10 Tx date 2018-10-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-250,000 vol |
250,000 | |
| Filed 2020-06-12 15:06 Tx date 2017-10-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-250,000 vol |
||
| Filed 2020-06-12 15:06 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 11:51 Tx date 2017-10-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-250,000 vol |
||
| Filed 2019-06-05 11:49 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-09 14:57 Tx date 2020-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+50,000 vol $0.065 each |
880,000 | |
| Filed 2020-01-09 14:57 Tx date 2020-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+50,000 vol $0.06 each |
830,000 | |
| Filed 2020-01-09 14:54 Tx date 2020-01-03 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+20,000 vol $0.065 each |
900,000 | |
| Filed 2020-01-03 06:17 Tx date 2020-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+100,000 vol |
||
| Filed 2020-01-03 06:17 Tx date 2020-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+100,000 vol |
880,000 | |
| Filed 2019-06-05 11:54 Tx date 2019-05-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,200
+30,000 vol $0.24 each |
780,000 | |
| Filed 2019-06-05 11:53 Tx date 2018-10-22 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+750,000 vol |
750,000 | |
| Filed 2019-06-05 11:52 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-05 11:51 Tx date 2017-10-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-250,000 vol |
250,000 | |
| Filed 2019-06-05 11:49 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2018-03-05 Tx date 2018-03-01 |
$BTH
Breathtec BioMedical, Inc. |
Moreau, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2015-07-08 Tx date 2015-07-08 |
$MOM
Miraculins Inc. |
Moreau, Christopher Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-210,000
-150,000 vol $1.40 each |
1,325,000 |